Results 281 to 290 of about 5,914,333 (296)

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

Lancet, The, 2019
John Yoo, Robert A Olson, Stewart Gaede
exaly  

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Lancet, The, 2016
Andrea Wang-Gillam, Chung-Pin Li, György Bodoky   +2 more
exaly  

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Ling-Long Tang, Wen-Fei Li, Xu Liu
exaly  

The Opening Phase: June 12

1981
openaire   +1 more source

Open Letter to Dr. L. Wittelshoefer

Ca-A Cancer Journal for Clinicians, 1972
exaly  

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)

Lancet, The, 2017
Antoni Ribas, Georgina V Long, Ana Arance   +2 more
exaly  

Phase 2: Opening

openaire   +1 more source

An Open Letter to Dr. Clarence Cook Little

Ca-A Cancer Journal for Clinicians, 1958
exaly  

The Opening Phase

openaire   +1 more source

Phase Transitions and Open Systems

2014
openaire   +1 more source